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I ABSTRACT 
Objective: To determine whether serum potassium ( K )  levels increase significantly following succinylcholine (SCh)- 
assisted intubation in ED patients. 
Methods: A prospective. noncontrolled, consecutive case series design was used to evaluate the change in serum K 
levels in E D  patients who received SCh for emergency intubation. The study was performed at  an academic medical 
center staffed by board-certified emergency physicians. The subjects were 100 consecutive prescreened E D  patients 
with various diagnoses who received SCh for intubation. The eligible subjects had serum K levels determined prior to 
and 5 minutes after administration of a 1 .O- 1 .S-mgikg IV dose of SCh. Serum K levels were measured by the ion- 
selective electrode assay method. 
Results: The mean change in serum K levels was -0.04 mmoliL (95% CI -0.14 to  0.06). The maximum increase was 
1.10 mmoliL. The serum K level rose in 46 cases, decreased in 46 cases, and was unchanged in eight cases. No instance 
of SCh-induced cardiac arrest was identified. 
Conclusion: Changes in serum K levels following SCh administration in prescreened E D  patients were minimal. A 
hyperkalemic response is uncommon in E D  patients who undergo SCh-assisted intubation. 
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I Succinylcholine (SCh)-assisted endotracheal intu- 
bation (ETI) has become increasingly more common in 
ED airway management over the past decade.’-‘ How- 
ever, SCh administration may lead to hyperkalemia and 
cardiovascular collapse in certain clinical situations. Case 
reports of SCh-induced hyperkalemia in multiple trauma 
and burn patients were first published in the  late 
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Since that time it has been recognized that other 
subsets of patients may be susceptible to SCh-induced 
hyperkalemia, including patients with neuromuscular 
diseases, near drowning, and serious infections. ’,’-I7 
However, in these cases, SCh was administered weeks 
to months after the initial acute disease process. 
Our English-language MEDLINE literature review 
found one “acute” case of SCh-induced hyperkalemic 
arrest in  a patient who had severe postpartum hemor- 
rhage and metabolic acidosis. IJ We found no reported 
case of SCh-induced hyperkalemia in the E D  care of 
patients with multiple trauma, burns, or neurologic or 
medical diseases. When conducting educational pro- 
grams on neuromuscular blockers and rapid-sequence 
intubation at a number of medical centers and confer- 
ences, the authors have found that some emergency 
physicians (EPs) are reluctant to use SCh to assist in- 
tubation because of concern over hyperkalemia and car- 
diovascular collapse. We therefore undertook a study 
of the change in serum potassium (K)  levels in ED 
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patients who received SCh for emergency intubation. 
The null hypothesis for this study was that SCh does 
not cause a significant elevation of serum K when ad- 
ministered in  the acute care of selected ED patients. 
I METHODS 
Study Design 
A prospective, noncontrolled, consecutive case se- 
ries design was used to study serial serum K levels in 
prescreened patient5 Lvho received SCh for ED ETI. 
I TABLE I Patient Exc luwn  Criteria 
A g e  2 years 
Prc5cntation with severe trauma. hurns. closed head injury. rup- 
rurcd cerebral aneurysm. neurornuscular disease. intra-abdominal 
infection. or near drowning where the disease process i s  >>24 hours 
in  duration 
Presentation with upper-airway ohstruction or acute epiglottitis. or 
;I condition for which cricothyrolorny would be difficult or i m p s -  
\ililc 
Pcnctr;iting eye injuries or glaucoma 
History of malignant hypertherrnia or pseudocholinesterasc defi- 
Known hyperkalemia 
Hcmolyzed hlood s;iniplcs 
ciency 
Population and Study Site 
The setting for the study was a university hospital 
ED with an annual census of approximately 50,000 pa- 
tient visits. All patients requiring ED ETI for whom 
the treating physician elected to use SCh to facilitate 
the intubation were eligible for the study. Those pa- 
tients who had multiple trauma. head injury, burns, and 
neuromuscular diseases whose disease processes were 
>24 hours old Here ineligible for the use of SCh and 
study enrollment. Additional exclusion criteria are noted 
in Table 1. The protocol was reviewed by the institu- 
tional review board. and informed consent was waived. 
The premise for this decision was that i t  was necessary 
and reasonable for a limited period of time to determine 
post-SCh K levels in all ED patients receiving SCh to 
ensure that post-SCh hyperkalemia was not occurring. 
Experimental Protocol 
A standard dose of 1.0-1.5 mgikg SCh was given 
at the discretion of the attending EP. A second dose 
was administered if needed, but blood sampling was 
done only after the first dose. Premedication with ve- 
curonium, a nondepolarizing neuromuscular blocker, 
to prevent SCh-induced fasciculations was given at the 
discretion of the attending EP. Some subjects also re- 
ceived atropine or lidocaine as premedication. All at- 
tending EPs had completed an educational program on 
the use of neuromuscular blockers prior to this study, 
and were aware of the study exclusion criteria. 
Measurements 
Serum was drawn for determination of K level Lvithin 
10 minutes of SCh administration and at 5 minutes post- 
dose by separate venous or arterial punctures. Five min- 
utes was selected as the time for post-SCh K measure- 
ment bawd on previous studies that found the maximal 
increase in K to occur 3 to 5 minutes after SCh admin- 
istration.' *. ' I  
All patients had cardiac monitoring and continuous 
pulse oximetry before, during, and for at least one hour 
after SCh administration. A nurse or  physician member 
of the ED team was responsible for continually watch- 
ing for and recording dysrhythmias from the time of 
SCh administration until  t he  5-minute post-SCh blood 
sample was obtained. 
Blood samples were analyzed in the hospital clinical 
laboratory by the ion-selective electrode assay method 
(Dupont Dimension AR).  Hemolysis was noted and 
recorded by the laboratory technician. Subjects who 
had more than slight hemolgsis on either pre- or post- 
SCh samples were excluded from the study. 
Data Analysis 
Descriptive statistics were used to analyze the data. 
Means 2 SDs and 95% CIS were calculated. Student's 
two-tailed t-test was used to compare the subjects who 
received vecuronium premedication and those who did 
not. The sample size of 100 subjects, assuming an SD 
of 0.5 mmoliL, with o! set at 0.05, provides a power of 
0.95 to detect a ?0.25-mmol/L change in serum K lev- 
els. 
I RESULTS 
One hundred seven subjects were enrolled in the study 
from June 1991 to January 1993. Six subjects were ex- 
cluded due to hemolyzed pre- or  post-SCh blood sam- 
ples. One subject was excluded because the pre-SCh 
blood sample was obtained hours before SCh admin- 
istration. The remaining 100 subjects constitute the study 
group. Violation of the clinical exclusion criteria was 
discovered in one case. A 71-year-old man who had 
suffered a head injury and traumatic aortic dissection 
in a motor vehicle crash was enrolled in the study. Fol- 
lowing SCh-assisted intubation it was learned that the 
patient was a wheelchair-bound paraplegic. The pre- 
SCh K level was 4.6 mmol/L, and the post-SCh K level 
was 4 . 1  mmol/L in this subject. Data for this subject 
were included in the study. 
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The primary diagnosis and indication for SCh-as- 
sisted intubation were grouped into five major cate- 
gories: trauma (including burn and traumatic brain in- 
j u r y ) ,  respiratory failure, neurologic disease, drug 
overdose, and medicalicardiac disease. The distribution 
and specific diagnoses of the subjects in these groups 
are shown in Table 2. The overall mean age was 43 * 
21 years. Five patients were <13 years old, and nine 
were >70 years old. 
Estimated weight was documented for 90 of the 100 
patients. The mean initial dosage of SCh was 1.1 mg/ 
kg (range 0.8 to 1.85 mg/kg). Three subjects received 
a second dose of SCh. For these patients, blood for 
determination of the post-SCh K level was drawn after 
the first SCh dose. Overall, the mean pre-SCh K level 
was 3.9 -+. 0.5 mmol/L, and the mean post-SCh K level 
was 3.9 L 0.6 mmol/L. The mean change in serum K 
levels was -0.03 z 0.49 mmol/L (95% CI - 0.14 to  
0.06) (Fig. 1). 
The serum K level rose in 46 patients following SCh 
administration, decreased in 46 patients, and remained 
the same in cight patients. The largest increase in serum 
K level was 1.10 mmol/L. This occurred in a patient 
who had facial and head trauma; the change was from 
3.3 mmoliL to 4.5 mmoliL. The post-SCh K level was 
>S mmol/L in only two patients. In the first case, a 
patient with status epilepticus had an increase in serum 
K level from 3.6 to 5.6 mmoliL following SCh admin- 
istration. Slight hemolysis was noted on the post-SCh 
specimen. In the second case, an asthmatic patient with 
respiratory arrest had an increase in serum K level from 
1.4 to 5.1 mmoliL following SCh administration. Slight 
hemolysis was noted in a pre-SCh sample in one case 
(the pre-SCh K level was 4.2  mmollL and the post-SCh 
K level was 3.6 mmol/L). No instance of post-SCh asys- 
tole, ventricular tachycardia, ventricular fibrillation, or  
cardiac arrest was identified for these 100 subjects. 
Documentation of the use of vecuronium prior to 
SCh administration could be determined for 85 sub- 
jects. Only 25 of these 8S subjects had received a stan- 
dard defasciculating dose of vecuroniurn prior to SCh 
administration. The distribution of diagnoses for these 
subjects was similar to that for the subjects who had 
not received vecuronium. The change in K level in the  
vecuronium premedication group was -0.036 z 0.24 
mmol/L. compared with -0.051 -+ 0.24 mmol/L for 
the 60 subjects who were documented as not receiving 
vecuronium (p = 0.79). 
I DISCUSSION 
Succinylcholine is routinely used in many EDs for rapid- 
sequence intubation. Our study is the first to assess the  
change in serum K level that occurs when ED patients 
receive SCh for a wide variety of indications. The results 
I TABLE 2 Diagnosis and or Indication for Succinylcholine-as- 
sisted lntubation ( n  = 100) 
N o  
Diagnosis Subject< 
Tr,iuma ( n  = 48) 
Head injury 1-4 
Multiple trauma 13 
Fmdl  fractures 4 
Burnismoke inhalation 2 
Aortic dissection 1 
Gunshot wound. face 1 
Stab wound. chest 1 
Cervical spine fracture I 
Neurologic (!I = 18) 
lntracerebral or subarachnoid hemorrhage 
Seizure 
Cerebrovascular accident 
Posterior fossa abscess 







MedicaliCardiovascular ( n  = 13) 
Congestive heart failure 
Gastrointestinal hemorrhage 
Acute myocardial infarction 
Aortic dissection 
Abdominal aortic aneurysm 
Re\piratorv (n = 6 )  
Pneumonia - 7 
Asthma 2 
Respiratory arrest 2 
of this study suggest that SCh-assisted intubation in 
selected ED patients with acute illnesses does not pro- 
duce significant changes in  serum K level. The average 
change in  serum K level was negligible, and no case of 
clinically important hyperkalemia was detected. It should 
be emphasized that the patients in this study were pre- 
screened. The attending EPs received an educational 
program on the use of SCh prior to the study. This 
educational program stressed the potential danger of 
using SCh for patients with multiple trauma, head in- 
ju ry ,  burns, or neurornuscular diseases when the disease 
process was >24 hours old. 
Numerous cases of SCh-induced hyperkalemic car- 
diac arrest have been reported in the medical literature. 
Most of these cases were reported i n  the late 1960s and 
1970s. ’- Since then. fewer cases have been reported. 
presumably because of measures to  prevent SCh-in- 
duced hyperkalemia in high-risk patients. Recently, a 
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number of cases of SCh-induced hyperkalemic arrest 
have been reported during induction of anesthesia in 
children with previously undiagnosed myopathies or 
clinically occult muscular dystrophy. I s -  I h  This has led 
some anesthesiologists to question the use of SCh for 
elective pediatric To date, similar cases 
have not been reported among E D  patients. 
Some data are available describing the "normal" 
changes in serum K level in patients who receive SCh. 
Schaner et al.' and Khan and Khan" found the mean 
increase in serum K level following SCh administration 
in patients undergoing elective surgery to be <0.4 mmoV 
L. Bourke found that while serum K levels. for which 
blood wa5 drawn 2 minutes after SCh administration in 
70 American Society of Anesthesiologists (ASA) class 
1 or 2 patients, changed significantly from baseline, the 
magnitude was not clinically important (i.e.. from 3.97 
2 0.07 to 4.18 5 0.10 mmol/L)." Dronen et al. found 
that  5-minute post-SCh serum K levels in 12 overdose 
patients were unchanged in 50% of cases, higher in 
33%. and lower in 17%, with an average rise in serum 
K level of 0.6 mmoliL." 
I t  is not clear whether SCh use is less safe for patients 
with severe shock or acidosis. Our study did not inves- 
tigate shock and acidosis, although it is likely, on re- 
viewing diagnoses. that several of our subjects had shock 
and/or acidosis. Succinylcholine is routinely used in the 
operating room for intubation in acute multiple trauma 
patients who have shock and acidosis, and we could 
find no case report of SCh-induced hyperkalemia in that 
setting. The only case report of SCh-induced hyper- 
kalemic arrest in an acutely i l l  patient was in a 42-year- 
old woman who had circulatory collapse three hours 
after an elective cesarean section." The patient had 
severe hemorrhagic shock from a uterine laceration. 
N i t h  a hematocrit of 19% and a serum bicarbonate con- 
centration of 5 mmoliL. Antognini and Gronert, using 
a rabbit model, found that hemorrhagic shock with pro- 
found metabolic acidosis led to hyperkalemia (mean K 
level 7.0 ? I .8 mmol/L) prior to administration of SCh, 
with a further increase following SCh admini~tration. '~ 
However. the largest case series in humans with "acute 
massive muscle trauma'' from battlefield injuries that 
were less than two hours old found only one case of 
hyperkalemia (without cardiac arrest) among 21 pa- 
tients. In this patient, the K level slowly rose to a max- 
imum of 6.2 mmol/L 20 minutes after SCh administra- 
tion, and the authors were not certain whether SCh 
caused the hyperkalemia.2J The presence of severe 
hemorrhagic shock or acidosis was not documented in 
this study. Further human data for the subset of patients 
who are in shock or acidotic who receive SCh are needed 
to determine whether SCh is contraindicated in this 
group. 
I LIMITATIONS AND FUTURE QUESTIONS 
Some limitations are present in our study. I t  is possible 
that by obtaining serum K samples at 5 minutes post- 
SCh administration. transient elevation of serum K that 
occurred between 1 and 5 minutes could have been 
missed. Most previous studies that have examined the 
timing of hyperkalemia following SCh administration 
have found the maximal increase to occur at 4 to 5 
minutes post-SCh administration."l'.'Z The exception 
to this is a study by Iwatsuki et al. of patients who had 
ruptured cerebral aneurysms and undcrwent surgery 
(days to weeks later) for repair. In  two of the 22 pa- 
tients, the serum K level rose markedly (to 10.0 and 
9.2 mmollL) following SCh administration. In  both of 
these patients. serum K levels were highest at 1 minute 
post-SCh administration and had decreased to 5.4 mmoV 
L and 6.3 mmol/L by 5 minutes post-SCh administra- 
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tion.?’ In  our study. no electrocardiographic evidence 
of hyperkalemia was observed in the first 5 minutes 
following SCh administration, making it unlikely that 
clinically significant hyperkalemia occurred during this 
period. 
A confounding factor in this study was the failure 
to control resuscitation medications prior to SCh use. 
Nondepolarizing neuromuscular blockers were used for 
approximately a third of the subjects, with no significant 
effect on the change in K level, when compared with 
the subjects who did not receive this premedication. 
The attending EPs elected to use vecuronium to prevent 
fasciculations on a case-by-case basis. I t  is possible that 
a hyperkalemic response from SCh was attenuated or 
prevented in some subjects by prior use of a nonde- 
polarizing agent. Atropine was routinely used for chil- 
dren. and lidocaine was used for some patients who had 
traumatic brain injury. Both of these agents, theoreti- 
cally. could affect hyperkalemic dysrhythmias. 
Our study had sufficient power to detect a significant 
change in serum K levels following SCh administration. 
To date this is the largest study of E D  patients that 
documents K levels following SCh administration. 
However. given the low incidence of hyperkalemia among 
ED patients w h o  receive SCh, a sample size of 100 is 
not sufficient for determining the true risk of hyper- 
kalemia or subgroups at higher risk. Further, while i t  
may be reasonable to assume that other ED patient 
populations would have similar K responses to SCh. i t  
must be emphasized that the subjects in our study were 
prescreened. Hyperkalemia induced by SCh may be 
seen more frequently when a patient selection process 
is not used. 
I CONCLUSION 
Succinylcholine is widely used for rapid-sequence in- 
tuhation in E D  patients. Average changes in serum K 
levels following SCh administration in prescreened ED 
patients were minimal. No instance of hyperkalemic 
cardiac arrest occurred. These findings suggest that a 
hyperkalemic response is uncommon in emergency pa- 
tients who require SCh-assisted intubation and when 
proper patient selection is used. 
The authors thank Dr. Alan Walsh for his work in designing and 
implementing the study. Dr. Susan Stern and Dr. Ron Maio for their 
help with data analysis. and Nancy Collins for preparing the manu- 
script. 
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